
Nutra Pharma CEO Rik Deitsch Interviewed by Stockguru.com
March 14, 2017 The interview provides an outline for Nutra Pharma’s growth plans over the next eighteen months. March 14, 2017 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis and HIV that also markets Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that Stockguru.com will be releasing an interview with Nutra Pharma’s CEO throu